These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20041843)

  • 21. Pharmacokinetics of opioids in renal dysfunction.
    Davies G; Kingswood C; Street M
    Clin Pharmacokinet; 1996 Dec; 31(6):410-22. PubMed ID: 8968655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pain treatment in reduced kidney function?].
    Martini B
    Med Monatsschr Pharm; 2007 Mar; 30(3):108-9. PubMed ID: 17405484
    [No Abstract]   [Full Text] [Related]  

  • 23. Opioid Analgesic Use among Patients with Kidney Disease: A Systematic Review.
    Liu S; Sands MB; Kerferd JW; Fathabadi S; Khor KE; Yiu CH; Phinn K; Anderson MA; Redmayne G; Yong K; Penm J
    Kidney Blood Press Res; 2024; 49(1):495-512. PubMed ID: 38824925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An exploratory study Evaluating the impact of opioid and non-opioid pain medications on serum/plasma free testosterone and free estradiol concentrations.
    Ray JA; Kushnir MM; Meikle AW; Sindt JE; Strathmann FG
    Drug Test Anal; 2017 Oct; 9(10):1555-1560. PubMed ID: 28182836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. a minireview.
    Ing Lorenzini K; Daali Y; Dayer P; Desmeules J
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):219-26. PubMed ID: 21995512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal impairment: a challenge for opioid treatment? The role of buprenorphine.
    Böger RH
    Palliat Med; 2006; 20 Suppl 1():s17-23. PubMed ID: 16764217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal impairment and analgesia: From effectiveness to adverse effects.
    Alizadeh R; Aghsaie Fard Z
    J Cell Physiol; 2019 Aug; 234(10):17205-17211. PubMed ID: 30916404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism and Disposition of Prescription Opioids: A Review.
    DePriest AZ; Puet BL; Holt AC; Roberts A; Cone EJ
    Forensic Sci Rev; 2015 Jul; 27(2):115-45. PubMed ID: 26227254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone: an effective alternative to morphine for pain relief in cancer patients.
    Shelton BW; Deynes-Romero J; Tofani-Montalvo M; Ramírez-Rivera J; Jaumne-Anselmi F
    Bol Asoc Med P R; 2008; 100(3):7-10. PubMed ID: 19227708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid equianalgesic conversion: the right dose.
    Brant JM
    Clin J Oncol Nurs; 2001; 5(4):163-5. PubMed ID: 12690618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of pain with peridural administration of opioids].
    Chrubasik S; Senninger N; Chrubasik J
    Chirurg; 1996 Jul; 67(7):665-70. PubMed ID: 8776538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
    Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
    Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine].
    Bono AV; Cuffari S
    Drugs; 1997; 53 Suppl 2():40-9. PubMed ID: 9190324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study.
    Kim DY; Song HS; Ahn JS; Ryoo BY; Shin DB; Yim CY; Kim SY
    Support Care Cancer; 2010 Feb; 19(2):297-301. PubMed ID: 20213238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.
    Ackerman SJ; Mordin M; Reblando J; Xu X; Schein J; Vallow S; Brennan M
    J Manag Care Pharm; 2003; 9(3):223-31. PubMed ID: 14613465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.